<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Guerbet Group; Withdrawal of Approval of Two New Drug Applications</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Guerbet Group; Withdrawal of Approval of Two New Drug Applications</h1>
    <p class="timestamp">Published: 2017-04-24 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is withdrawing approval of two new drug applications (NDAs) held by Guerbet Group. Guerbet Group notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-08179</p>
    <p><strong>Publication Date:</strong> 2017-04-24</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/04/24/2017-08179/guerbet-group-withdrawal-of-approval-of-two-new-drug-applications">https://www.federalregister.gov/documents/2017/04/24/2017-08179/guerbet-group-withdrawal-of-approval-of-two-new-drug-applications</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-08179</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
